NCT04014504

Pethidine Analgesia and Neonatal Hearing Screening Test

Effect of Pethidine Analgesia on False Positivity in Neonatal Hearing Screening Test

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 150 (actual)
• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
• Sex: Female
• Age: 24 Hours – 14 Days
• Healthy volunteers: Not accepted

Summary

Neonatal hearing screening may fail due to some perinatal and neonatal factors. It is well known that false positivity in newborn hearing screening increases cost and maternal anxiety and anxiety. There is still widespread concern about the use of opoid analgesics to relieve pain during labor. The aim of this study was to determine the effects of pethidine administered during labor on neonatal hearing screening test false positivity rates.

Detailed description

The study group consisted of patients receiving 50 mg intramuscular (I.M) pethidine at the beginning of the active phase of labor and the control group consisted of patients not receiving pethidine. Newborns were evaluated by otoacoustic emission (OAE) test. The OAE test was performed before the patients were discharged. Perinatal and neonatal variables and test results were recorded and the relationship between false positivity and pethidine use was evaluated.

Conditions

• Hearing Loss
• Newborn Complication

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Neonatal Hearing Screening Test	neonatal hearing screening test results will be evaluated.

Timeline

• Start date: 2017-01-01
• Primary completion: 2018-01-01
• Completion: 2018-01-01
• First posted: 2019-07-10
• Last updated: 2019-07-12

Locations

1 site across 1 country: Turkey (Türkiye)